PACB Stock-Based Compensation
Pacific Biosciences Of California · Stock-Based Compensation
PACB Stock-Based Compensation
Latest reported$23.31Mperiod ending
PACB TTM Stock-Based Comp ($9.69M → $23.31M)
TTM stock-based compensation
High-resolution chart · PNG
PACB stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 23,310,000 | |
| 9,588,000 | |
| 18,789,000 | |
| 25,234,000 | |
| 43,493,000 | |
| 60,712,000 | |
| 71,036,000 | |
| 71,587,000 | |
| 73,019,000 | |
| 55,800,000 | |
| 54,227,000 | |
| 55,598,000 | |
| 35,907,000 | |
| 35,907,000 | |
| 17,955,000 | |
| 18,938,000 | |
| 18,938,000 | |
| 34,743,000 | |
| 44,908,000 | |
| 31,245,000 | |
| 36,237,000 | |
| 23,666,000 | |
| 17,533,000 | |
| 16,127,000 | |
| 15,197,000 | |
| 16,052,000 | |
| 16,401,000 | |
| 20,054,000 | |
| 21,117,000 | |
| 22,252,000 | |
| 23,153,000 | |
| 21,021,000 | |
| 20,864,000 | |
| 20,650,000 | |
| 20,353,000 | |
| 19,799,000 | |
| 19,938,000 | |
| 19,966,000 | |
| 19,562,000 | |
| 18,753,000 | |
| 16,884,000 | |
| 15,166,000 | |
| 13,840,000 | |
| 12,812,000 | |
| 12,026,000 | |
| 10,928,000 | |
| 9,943,000 | |
| 9,488,000 | |
| 9,207,000 | |
| 9,429,000 | |
| 9,905,000 | |
| 9,908,000 | |
| 10,125,000 | |
| 10,264,000 | |
| 9,705,000 | |
| 10,442,000 | |
| 11,043,000 | |
| 11,467,000 | |
| 12,384,000 | |
| 12,522,000 | |
| 11,796,000 | |
| 10,695,000 | |
| 9,690,000 | |
| 7,285,000 | |
| 5,999,000 |